Suven Life Sciences posts Q2FY23 consolidated loss at Rs. 23.18 Cr

The company has reported total income of Rs. 4.59 crores during the period ended September 30, 2022

GSK India announces 9% sales growth across General Medicines and Specialty business

The company hopes to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth

Sanofi, GSK’s next-generation COVID-19 booster vaccine approved by the European Commission

First and only next-generation protein-based adjuvanted COVID-19 booster approved in Europe

Pfizer and BioNTech receive positive CHMP opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster

The European Commission will review the CHMP recommendation and is expected to make a final decision soon.

Themis Medicare revenue down 15.26%; Profit down 7.76%

For the half year ended September 30th, 2022 revenue from operations stood at Rs. 185.44 crore in H1 FY23, as against Rs. 219.89 crore in H1 FY22, a decrease of 15.67%

Piramal Phamra reports Q2 FY23 consolidated loss at Rs. 37.34 Cr

Vinati Organics consolidated Q2FY23 PAT up 43% at Rs. 116 Cr

The company posted net profit of Rs.81.33 crores for the quarter ended September 30, 2021.

IOLCP receives EDQM certification to supply Pantoprazole Sodium Sesquihydrate API in Europe

Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion

EMPA-KIDNEY trial showed significant benefit of Jardiance in reducing kidney disease progression

Phase III trial also demonstrated a statistically significant reduction (14%) in hospitalization for any cause, bringing potential relief for patients and reducing burden on healthcare systems

GMM Pfaudler Q2FY23 consolidated profit up at Rs. 64.98 Cr

The company has reported total income of Rs. 799.52 crores during the period ended September 30, 2022